Combined N ‐terminal androgen receptor and autophagy inhibition increases the antitumor effect in enzalutamide sensitive and enzalutamide resistant prostate cancer cells

The Prostate, EarlyView.

Source: The Prostate - October 22, 2018 Category: Urology & Nephrology Authors: Benedikt Kranzb ühler, Souzan Salemi, Ashkan Mortezavi, Tullio Sulser, Daniel Eberli Source Type: research